ABSTRACT Background The recommendation of cosmetic products in dermatological practice has become increasingly common, driven by the evolution of formulations and active ingredients that sometimes mirror pharmacological effects. This convergence has blurred the boundaries between cosmetics and medications, creating uncertainty among professionals regarding product efficacy and classification. Additionally, dermatologists face challenges interpreting label information, which is often technical, fragmented, or lacks standardization, undermining clarity and clinical confidence. Objective This study aimed to evaluate dermatologists' understanding of the labeling information on cosmetic products they prescribe or recommend. Methods Structured interviews were conducted with 118 Brazilian dermatologists using a 29‐question instrument (multiple‐choice, open‐ended, and scaled formats). Descriptive analysis was performed using specific statistical software 1 . Results Most participants regularly prescribe cosmetics or dermocosmetics and value labeling information. However, they report difficulties interpreting data and defining terms such as “claim” and “natural product.” Industry communication, particularly via medical detailing (industry representatives) and congresses, strongly influences prescribing decisions. There is a clear demand for objective information on composition, active concentration, safe use, and scientific evidence of efficacy. Conclusion Participants suggested improving communication between the cosmetics industry and dermatologists by providing clear, standardized information on ingredients, concentrations, usage guidelines, efficacy, adverse effects, and safety during pregnancy. These findings reinforce the need for tools that support informed clinical practice.
Vendruscolo et al. (Sun,) studied this question.